3FunkM L, RosenbergD M, Lok A S. Word2wide ep idemiology of HbeAg-negative chronic hepatitis B and associated p recore and core promoter variants[J]. J Viral Hepat, 2002, 9:52 -56.
4Valentine2Thon E. Quality control in nucleic acid testing2where do we stand[J]. Clin Virol, 2002, 25 ( Supp 1 3): 13-21.
5SchuttenM. Niesters HG. Clinical utility of viral quantification as a tool for disease monitoring[ J]. Expert Rev Mol Diagn, 2001, 1:153 - 162.
6Niesters H G. Molecular and diagnostic clinical virology in real time[J]. ClinMicrobiol Infect, 2004, 10:5 - 11.
6PfeifeRK,PelzeRC,Coleman P,et al. Early detection of hepatitis B surface antigen-prototype of a new fully automated HBsAg microparticle enzyme immunoassay[J].Clin.Lab.2003, 49:161-166.
7Funk M L,Rosenberg D M, Lok A S.Word-wide epidemiology of HbeAg-negative chronic hepatitis B and associated precore and core promoteRvariants[J].J Viral Hepat,2002,9:52-56.
8Valentine-Thon E.Quality control in nucleic acid testing-where do we stand[J].Clin Virol,2002,25(Suppl 3):13-21.
9Schutten M.Niesters HG.Clinical utility of viral quantification as a tool foRdisease monitoring[J].Expert Rev Mol Diagn,2001,1:153-162.
10Niesters H G.MoleculaRand diagnostic clinical virology in real time[J].Clin Microbiol Infect,2004,10:5-11.
1Tran T T, Trinh T N, Abe K. New complex recombinant geno- type of hepatitis B virus identified in Vietnam [ J ]. J Virol, 2008, 82( 11 ) : 5657 - 5663.
2Yu M W, Yeh S H, Chen P J, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men[ J]. J Natl Cancer Inst, 2005, 97 (4) : 265 - 272.
3Liu C J, Kao J H. Genetic variability of hepatitis B virus and re-sponse to antiviral therapy [ J ]. Antivir Ther, 2008, 13 ( 5 ) : 613 -624.
4Ganem D, Prince A M. Hepatitis B virus infection--natural his- tory and clinical consequences [ J]. N Engl J Med, 2004, 350 (11): 1118 -1129.
5Liang X, Bi S, Yang W, et al. Evaluation of the impact of hepa- titis B vaccination among children born during 1992 -2005 in China[ J]. J Infect Dis, 2009, 200 ( 1 ) : 39 -47.
6Liaw Y F. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment[ J]. Liver Int, 2009, 29 Suppl 1:100 - 107.
7McMahon B J. The natural history of chronic hepatitis B virus in- fection [ J ]. Hepatology, 2009, 49 ( 5 Suppl) : S45 - 55.
8Sokal E M, Kelly D, Wirth S, et al. The pharmacokinetics and safety of adefovir dipivoxil in children and adolescents with chron- ic hepatitis B virus infection [ J ]. J Clin Pharmacol, 2008, 48 (4):512 -517.
